Triple Negative Breast Cancer
Triple negative breast cancer is a particularly aggressive and invasive type of breast cancer. It is difficult to treat because of the lack of receptors on the surface of the cancer cells. The 413 Foundation is committed to helping to find better treatment options and eventually a cure for this disease. Dr. Russell was a triple negative cancer patient.
What is Triple Negative Breast Cancer?
Triple-negative breast cancer (sometimes abbreviated TNBC) refers to any breast cancer that does not express the genes for estrogen receptor (ER), progesterone receptor (PR) or Her2/neu.This makes it more difficult to treat since most hormone therapies target one of the three receptors, so triple-negative cancers often require combination therapies. Triple negative is sometimes used as a surrogate term for basal-like; however, more detailed classification may provide better guidance for treatment and better estimates for prognosis. Read more here: Triple Negative Breast Cancer
